LUMEXA IMAGING HOLDINGS INC

LMRINASDAQ

🏆 #2114 by market capEarnings Aug 12US Equity

$11.46▼ $0.20 (−1.72%)

Live

1h▼ 1.6%

24h▼ 1.7%

7d▲ 1.5%

14d▲ 11.0%

30d▲ 2.6%

1y—

🏦Market Cap

$1.10B

Small Cap

📈Revenue Growth (YoY)

+7.8%

Slowing

📊Gross Margin

10.5%

Thin

💵FCF Margin

2.0%

Thin

⚖️P/S Ratio

2.1x

Cheap

Otter Score

Fair

Trading Snapshot

Day Range: $11.30 – $11.55
52-Week Range: $6.45 – $19.45
Volume: $2.78B
Avg Volume: $1.86B
Shares Outstanding: 96.1M
Next Earnings: Sep 18, 2026

Fundamentals Snapshot

Annual Revenue: $1.02B
Last Q Revenue: $253M
P/E Ratio: -31.6
P/S Ratio: 2.1x
EPS (TTM): $-0.28
Dividend Yield: 0.00%

Why Investors Own LMRI

✓High-growth profile — revenue up +3.5% YoY with expanding US Equity exposure.
✓Healthy economics — 29% gross margin and 21% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$1.02B▲ +2.0% YoY

Gross Margin (TTM)

28.7%▲ +0.0% YoY

Operating Income (TTM)

$253M▲ +2.0% YoY

Free Cash Flow (TTM)

$215M▲ +2.0% YoY

About LUMEXA IMAGING HOLDINGS INC

Lumexa Imaging Holdings, Inc. manages and operates diagnostic imaging centers throughout the United States. These facilities deliver a comprehensive range of outpatient medical imaging solutions, encompassing advanced procedures like Magnetic Resonance Imaging (MRI), Computed Tomography (CT), and Positron Emission Tomography (PET) scans, in addition to standard diagnostic and screening services such as X-rays, ultrasounds, and mammography. The company was founded in 2018 and its primary base of operations is in Raleigh, North Carolina.

🦦